Simulations Plus, Inc. (SLP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Simulations Plus, Inc. (SLP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Simulations Plus, Inc. (SLP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Simulations Plus, Inc. (SLP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
21 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Simulations Plus, Inc. (Simulations Plus) is a pharmaceutical company that develops and markets software for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity (ADMET) modeling and simulation software. Its products include GastroPlus, ADMET Predictor, MedChem Studio, DDDPlus, MedChem Designer, ADMET Design Suite, Biorelevant Solubility Database and MembranePlus. Simulations Plus GastroPlus is a physiologically based pharmacokinetic modeling and simulation software package that simulates intravenous, oral, oral cavity, ocular, inhalation, pharmacokinetics, and pharmacodynamics in human and animals.

Simulations Plus, Inc. (SLP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped

  
Source:
Document ID
GDPH131162D
Country
Industry
Ticker
SLP=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Simulations Plus, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Simulations Plus, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Simulations Plus, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Simulations Plus, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Simulations Plus, Inc., Medical Devices Deals, 2010 to YTD 201691
Simulations Plus, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Simulations Plus, Inc., Pharmaceuticals &Healthcare, Deal Details117
  Asset Purchase111
    Simulations Plus To Acquire Software Royalty Agreement From Enslein Research For US$0.8 Million111
  Partnerships121
    Simulations Plus Enters Into Distribution Agreement With Research Institute for Liver Diseases121
    Simulations Plus Enters Into Agreement With Pharma Company131
  Licensing Agreements141
    Simulations Plus Enters into Licensing Agreement with Dow Chemical141
    Simulations Plus Terminates Licensing Agreement with TSRL151
  Acquisition161
    Simulations Plus Acquires Cognigen for USD7 Million161
    Simulations Plus Terminates The Acquisition Of Entelos171
Simulations Plus, Inc. - Key Competitors181
Key Employees191
Locations And Subsidiaries201
  Head Office201
  Other Locations &Subsidiaries201
Appendix211
  Methodology211
  About GlobalData211
  Contact Us211
  Disclaimer211

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Simulations Plus, Inc. (SLP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Simulations-Plus-Inc-SLP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23729>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Simulations Plus, Inc. (SLP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Simulations-Plus-Inc-SLP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23729>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research